NeuWave Medical, Inc.

NeuWave Medical, Inc., a wholly owned subsidiary of Quantum Surgical, Inc., specializes in developing and commercializing energy-based minimally invasive microwave ablation systems for soft tissue treatment. The company's flagship NeuWave™ Microwave Ablation System is indicated for percutaneous, open surgical, and laparoscopic-assisted ablation of non-resectable liver tumors and soft tissue lesions. The system features ABLATE-IQ™ technology for pre- and post-ablation scan fusion and margin confirmation, Tissu-Loc™ technology using CO2 cooling to minimize probe migration, and a comprehensive probe portfolio including the PRS35 probe with 35cm length for enhanced anatomical reach. The system supports multi-probe synchrony (1–3 probes) to create larger, more spherical ablation zones tailored to individual patient anatomy. Having served over 100,000 patients worldwide, NeuWave continues to pioneer microwave ablation standards and deliver clinical support through live case assistance, virtual clinical concierge services, and comprehensive procedural guidance resources.